L. Tenenbaum et al., PLASTIC PHENOTYPE OF HUMAN OLIGODENDROGLIAL TUMOR-CELLS IN-VITRO, Neuropathology and applied neurobiology, 22(4), 1996, pp. 302-310
Human oligodendroglioma cells cultured in serum-supplemented media los
e their oligodendrocytic antigenic markers and acquire astrocytic mark
ers. However, after reimplantation in rodent brain, these cells re-exp
ress oligodendrocytic markers. This switch in human oligodendroglioma
cell phenotype could result from the interplay of different stimuli in
vitro vs in vivo, The ii vitro differentiation into astrocytes might
result from non-physiological culture conditions. It is shown that hum
an oligodendroglioma cells behave in a way similar to that of rodent b
ipotential 0-2 A progenitor cells which can be driven to differentiate
into either oligodendrocytes or type 2-astrocytes depending on the cu
lture medium. Indeed, in serum-supplemented medium, human oligodendrog
lioma cells proliferated and expressed the GFAP astrocytic marker. In
chemically defined medium containing insulin, human oligodendroglioma
cells were quiescent and expressed the 01 oligodendrocyte-specific mar
ker. In both media, human oligodendroglioma cells expressed the A2B5 m
embrane marker as well as the SCIP transcription factor specific of 0-
2 A cells, further confirming their oligodendrocytic origin. Replaceme
nt of insulin by platelet-derived growth factor (PDGF) and basic fibro
blast growth factor (bFGF), known to maintain 0-2 A progenitors in a p
roliferative state, stimulated DNA replication of human oligodendrogli
oma cells cultured in chemically defined medium.